期刊文献+

布洛芬注射液的制备及其稳定性考察 被引量:6

Preparation and Stability Investigation of Ibuprofen Injection
下载PDF
导出
摘要 目的:通过影响因素试验和配伍稳定性试验考察自制布洛芬注射液的稳定性。方法:以精氨酸作为助溶剂,与布洛芬按1︰1摩尔比配制布洛芬注射液;通过影响因素试验(强光、高温和冻融试验),考察注射液稳定性;与0.9%氯化钠注射液和5%葡萄糖注射液配伍,考察24 h内的配伍稳定性。结果:制得的布洛芬注射液无色澄明,pH值在7.8左右;经影响因素试验考察,各指标无明显变化;配伍稳定性实验结果显示,与两种输液配伍后24 h内,配伍液外观和pH值均无明显变化,布洛芬含量基本没有变化,有关物质检查合格。结论:制备的布洛芬注射液经影响因素考察稳定性良好,与两种输液在25℃、24 h内配伍稳定。 Objective: To prepare and study the stability of ibuprofen injection with stress tests and compatibility test.Methods: Prepare ibuprofen injection with arginine as the solubilizing agent.Investigate the stability of the injection with highlight(4500 lx±500 lx),high temperature(60℃) and repetitive freeze-thawing tests.The contents of ibuprofen injection in two mixed solution within 24 hours were detemined by HPLC,and the appearance and pH value of the mixed solutions were also examined.Results: Ibuprofen injection was colorless and clear.No significant change was found in appearance,pH,content of ibuprofen injection and related substance after the stress tests or being mixed with two infusions.Conclusion: Ibuprofen injection had a good stability in stress conditions and a good compatibility with two infusions at 25℃ in 24 h.
出处 《药学与临床研究》 2011年第2期186-188,共3页 Pharmaceutical and Clinical Research
基金 国家科技支撑计划(2008BAI55B03) 新制剂与新释药系统技术平台重大专项(2009ZX09310-004)
关键词 布洛芬注射液 稳定性 影响因素试验 配伍 Ibuprofen Injection Stability Stress Tests Compatibility
  • 相关文献

参考文献2

  • 1Morris PE,Promes JT,Guntupalli KK,et al.A multicenter,randomized,double-blind,parallel,placebo-controlled trial to evaluate the efficacy,safety,and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults[J].Crit Care,2010,14(4):1-13.
  • 2Farmer S,Anderson P,Burns P,et al.Forced degradation of ibuprofen in bulk drug and tablets and determination of specificity,selectivity,and the stabilityindicating nature of the USP ibuprofen assay method[J].Pharm Technol,2002:28-42.

同被引文献34

  • 1周卫,平其能,王丽杰.羟喜树碱脂质体的粒径对组织分布的影响[J].中国药科大学学报,2005,36(2):125-128. 被引量:15
  • 2甘黎光.国外非甾体消炎药的发展与动向[J].中国新药杂志,1994,3(4):53-62. 被引量:25
  • 3张桂杰,张桂华.环氧合酶(COX)在牙髓组织中的表达及其预防应用价值[J].中国卫生工程学,2006,5(3):185-186. 被引量:1
  • 4《化学药物刺激性、过敏性和溶血性研究技术指导原则》课题研究组.化学药物刺激性、过敏性和溶血性研究技术指导原则[S].北京:中国食品药品监督管理局,2005..
  • 5VOLONTE MG, VALORA PD, CINGOLANI A,et al. Stability of ibuprofen in injection solutions [ J]. Am J Health Syst Pharm, 2005,62(6) :630 - 633.
  • 6SHABIR GA, HAMID A, ARAIN SA. Development and valida- tion of an HPLC method for the determination of 2-(4-Isobutyl- phenyl) propionic acid and 4-Isobutylacetophenone in a gel tech- nologies formulation[J]. J Liq Chromatogr & Rel Technol,2008, 31(4) :497 -508.
  • 7USP. XXX Ⅱ. P2607.
  • 8张丽娜,龚华,艾宇航.急性肺损伤大鼠肺组织COX-2、NF-κB表达及其相关性的研究[J].医学临床研究,2007,24(11):1872-1875. 被引量:9
  • 9《化学药物刺激性、过敏性和溶血性研究技术指导原则》课题研究组.化学药物刺激性、过敏性和溶血性研究技术指导原则[J].国家食品药品监督管理局药品审评中心,2013:33-52.
  • 10Walson P D, GaUetta G, Braden N J, et al. Ibuprofen, acetaminophen, and placebo treatment of febrile children[J]. Clin Pharmacol Ther, 1989,46(1):9-17.

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部